2127: Guselkumab Provides Continued Improvement in Key Domains of Psoriatic Arthritis Through 2 Years

Coates, L., Gossec, L., Contre, C. et al. (8 more authors) (2022) 2127: Guselkumab Provides Continued Improvement in Key Domains of Psoriatic Arthritis Through 2 Years. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 4214-4216.

Metadata

Authors/Creators:
  • Coates, L.
  • Gossec, L.
  • Contre, C.
  • Shawi, M.
  • Rampakakis, E.
  • Shiff, N.
  • Kollmeier, A.
  • Xu, X.L.
  • Nash, P.
  • Mease, P.J.
  • Helliwell, P.
Dates:
  • Published (online): 29 September 2022
  • Published: 29 September 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 22 Aug 2023 13:39
Last Modified: 22 Aug 2023 13:39
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1002/art.42355
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)